Aurinia Pharmaceuticals (AUPH) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Atmosphere Carbon Footprint Circular Climate Climate Change CO2 Emission Environment Environmental Environmental Protection Flaring Greenhouse Gas Emission Materials Nature Offset Package Packaging Pandemic Planet Raw Materials Regenerative Renewable Scarcity Waste Water Wind Access Access and affordability Affordability Asian Benefits Black Charitable Charity Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographics Disability Diversity Employee Employee Retention Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury LGBTQ Minority Pay for Performance Perquisites Privacy Product Quality Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Women Working Condition Anti-corruption Assessment Assurance Attorney General Attorneys General Audit Board Refreshment Bonus Bribery Chronic Class Action Lawsuit Classified Clawback Commitment Conflict of Interest Controversy Corporate Governance Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Independent Chair Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Plaintiff Poison Pill Procurement Proxy Access Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Resilient Responsibility Responsible Shareholder Proposals Special Meeting Stewardship Strategy Sustainability Targets Tax Tax Gross Up Tenure Term Limit Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

(a)The Company held the 2022 Meeting virtually on May 17, 2022.

(b)The following proposals were voted upon at the 2022 Meeting and the final voting results with respect to each such proposal are set forth below:

Proposal 1: Based upon the following votes, the shareholders elected Dr. George Milne, Mr. Peter Greenleaf, Dr. David R.W. Jayne, Mr. Joseph P. Hagan, Dr. Daniel Billen, Mr. R. Hector MacKay-Dunn, Ms. Jill Leversage, Mr. Timothy P. Walbert and Dr. Brinda Balakrishnan to serve as members of the Company's board of directors until the annual general meeting of shareholders to be held in 2023.

Nominee	For	Withheld	Broker Non-Votes

Dr. George Milne	26,713,176	17,437,781	27,895,212
Mr. Peter Greenleaf	31,700,200	12,450,757	27,895,212
Dr. David R.W. Jayne	33,300,962	10,859,995	27,895,212
Mr. Joseph P. Hagan	24,070,897	20,080,060	27,895,212
Dr. Daniel Billen	33,482,518	10,668,439	27,895,212
Mr. R. Hector MacKay-Dunn	26,206,913	17,944,044	27,895,212
Ms. Jill Leversage	27,594,235	16,556,722	27,895,212
Mr. Timothy P. Walbert	33,368,946	10,782,011	27,895,212
Dr. Brinda Balakrishnan	34,251,064	9,899,893	27,895,212

Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2023 or until a successor is appointed.


For	Against	Abstain
63,341,990	6,693,240	2,000,938

Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.

For						Against						Abstain						Broker Non-Votes

33,050,501						10,490,227						610,231						27,895,210